Bg pattern

BRETARIS GENUAIR (Inhalation Capsule)

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BRETARIS GENUAIR (Inhalation Capsule)

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Bretaris Genuair 322micrograms powder for inhalation

aclidinium (aclidinium bromide)

Read this package leaflet carefully before you start using this medicine, because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the package leaflet:

  1. What is Bretaris Genuair and what is it used for
  2. What you need to know before you start using Bretaris Genuair
  3. How to use Bretaris Genuair
  4. Possible side effects
  5. Storage of Bretaris Genuair
  6. Contents of the pack and further information

Instructions for use

1. What is Bretaris Genuair and what is it used for

What is Bretaris Genuair

The active substance of Bretaris Genuair is aclidinium bromide, which belongs to a class of medicines called bronchodilators. Bronchodilators relax the airways and help keep the bronchioles open. Bretaris Genuair is a dry powder inhaler that uses your breath to deliver the medicine directly into the lungs. This makes it easier for patients with chronic obstructive pulmonary disease (COPD) to breathe.

What is Bretaris Genuair used for

Bretaris Genuair is indicated to help open up the airways and relieve the symptoms of COPD, a serious long-term lung disease that makes it difficult to breathe. Regular use of Bretaris Genuair can help you when you experience persistent difficulty breathing due to the disease, to help minimize the effects of the disease on your daily life, and reduce the number of exacerbations (worsening of COPD symptoms over several days).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you start using Bretaris Genuair

Do not use Bretaris Genuair:

  • if you are allergic to aclidinium bromide or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you start using Bretaris Genuair:

  • if you have heart problems;
  • if you see halos around lights or colored images (glaucoma);
  • if you have an enlarged prostate, problems urinating, or an obstruction in your bladder.

Bretaris Genuair is indicated for maintenance treatment and should not be used to treat a sudden attack of difficulty breathing or wheezing. If your COPD symptoms (difficulty breathing, wheezing, or coughing) do not improve or worsen, you should consult your doctor as soon as possible.

Dry mouth, which has been observed with medicines like Bretaris Genuair, may be associated with tooth decay after prolonged use of the medicine. Therefore, remember to take care of your oral hygiene.

Stop using Bretaris Genuair and seek medical help immediately if:

  • you notice chest tightness, coughing, wheezing, or difficulty breathing immediately after using this medicine. These may be signs of a condition called bronchospasm.

Children and adolescents

Bretaris Genuair should not be used in children or adolescents under 18 years of age.

Using Bretaris Genuair with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Inform your doctor if you have used or are using similar medicines for respiratory problems, such as medicines containing tiotropium, ipratropium. In case of doubt, consult your doctor or pharmacist. The use of Bretaris Genuair with these medicines is not recommended.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. You should not use Bretaris Genuair if you are pregnant or breastfeeding unless your doctor has recommended it.

Driving and using machines

Bretaris Genuair has a minor influence on the ability to drive and use machines. This medicine may cause headache, dizziness, or blurred vision. If you experience any of these adverse reactions, do not drive or use machines until your headache has disappeared, the feeling of dizziness has passed, and your vision has returned to normal.

Bretaris Genuair contains lactose

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

3. How to use Bretaris Genuair

Follow exactly the instructions for administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.

The recommended dose is one inhalation twice a day, in the morning and in the evening.

The effects of Bretaris Genuair last 12 hours, so you should try to use the Bretaris Genuair inhaler at the same time every morning and evening. This will ensure that there is always enough medicine in your body to help you breathe more easily throughout the day and night. This will also help you remember to use it.

The recommended dose can be used in elderly patients and in patients with kidney or liver problems. No dose adjustment is necessary.

COPD is a long-term disease, so it is recommended to use Bretaris Genuair every day, twice a day, and not just when you have breathing problems or other COPD symptoms.

Method of administration

This medicine is for inhalation use only.

Refer to the Instructions for Use to learn how to use the Genuair inhaler. If you are in doubt about how to use Bretaris Genuair, consult your doctor or pharmacist.

You can use Bretaris Genuair at any time, before or after meals or drinks.

If you use more Bretaris Genuair than you should

If you think you have used more Bretaris Genuair than you should, talk to your doctor or pharmacist.

If you forget to use Bretaris Genuair

If you miss a dose of Bretaris Genuair, inhale the dose as soon as you remember. However, if it is almost time for your next dose, skip the missed dose.

Do not take a double dose to make up for a forgotten dose.

If you stop using Bretaris Genuair

This medicine is for long-term treatment. If you want to stop treatment, consult your doctor first, as your symptoms may worsen.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Bretaris Genuair can cause side effects, although not everybody gets them.

In rare cases, allergic reactions (may affect up to 1 in 1,000 patients) can occur. Stop using the medicine and contact your doctor immediately if you experience swelling of the face, throat, lips, or tongue (with or without difficulty breathing or swallowing), dizziness or fainting, rapid heartbeat, or severe swelling with itching of the skin (hives), as these may be symptoms of an allergic reaction.

The following side effects may occur when using Bretaris Genuair:

Common:may affect up to 1 in 10 patients

  • Headache
  • Inflammation of the paranasal sinuses (sinusitis)
  • Common cold (nasopharyngitis)
  • Cough
  • Diarrhea
  • Nausea

Uncommon:may affect up to 1 in 100 patients

  • Dizziness
  • Dry mouth
  • Inflammation of the mouth (stomatitis)
  • Hoarseness (dysphonia)
  • Increased heart rate (tachycardia)
  • Feeling of heart pounding (palpitations)
  • Abnormal or irregular heartbeat (arrhythmias)
  • Difficulty urinating (urinary retention)
  • Blurred vision
  • Rash
  • Itching of the skin

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Bretaris Genuair

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the inhaler label and the carton after “EXP”. The expiry date is the last day of the month shown.

Keep the Genuair inhaler in the bag until you start treatment.

Use within 90 days of opening the bag.

Do not use Bretaris Genuair if you notice the packaging is damaged or shows signs of tampering.

Once you have used the last dose, the inhaler should be discarded. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package Contents and Additional Information

Bretaris Genuair Composition

  • The active ingredient is aclidinium bromide. Each delivered dose contains 375 micrograms of aclidinium bromide equivalent to 322 micrograms of aclidinium.
  • The other component is lactose monohydrate (see section 2 "Bretaris Genuair contains lactose").

Appearance of the Product and Package Contents

Bretaris Genuair is a white or almost white powder.

The Genuair inhaler device is white with an integrated dose indicator and a green dosing button. The mouthpiece is covered by a removable green protective cap. It is provided in a plastic bag.

Available package sizes:

Package containing 1 inhaler with 30 doses.

Package containing 1 inhaler with 60 doses.

Package containing 3 inhalers with 60 doses each.

Only some package sizes may be marketed.

Marketing Authorization Holder

Covis Pharma Europe B.V.

Gustav Mahlerplein 2

1082MA Amsterdam

Netherlands

Manufacturer

Industrias Farmacéuticas Almirall, S.A.

Ctra. de Martorell 41-61

08740 Sant Andreu de la Barca, Barcelona

Spain

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

Belgium/Belgique/Belgien

Covis Pharma Europe B.V.

Tel: 80013067

Lithuania

UAB "BERLIN-CHEMIE MENARINI BALTIC"

Tel: +370 52 691 947

Text in Bulgarian language with contact information of a pharmaceutical company and phone number

Luxembourg/Luxemburg

Covis Pharma Europe B.V.

Tel: 80024119

Czech Republic

Berlin-Chemie/A.Menarini Ceska republika s.r.o.

Tel: +420 267 199 333

Hungary

Berlin-Chemie/A. Menarini Kft.

Tel.: +36 23501301

Denmark

Covis Pharma Europe B.V.

Tlf: 80711260

Malta

Covis Pharma Europe B.V.

Tel: 80065149

Germany

Berlin-Chemie AG

Tel: +49 (0) 30 67070

Covis Pharma Europe B.V.

Tel: +49 (0) 3031196978

Netherlands

Covis Pharma Europe B.V. Tel: 08000270008

Estonia

OÜ Berlin-Chemie Menarini Eesti

Tel: +372 667 5001

Norway

Covis Pharma Europe B.V. Tlf: 80031492

Greece

MENARINI HELLAS AE

Τηλ: +30 210 8316111-13

Austria

  • Menarini Pharma GmbH.

Tel: +43 1 879 95 85-0

Spain

Laboratorios Menarini S.A.

Tel: +34-93 462 88 00

Poland

Covis Pharma Europe B.V. Tel.: 0800919353

France

MENARINI France

Tél: +33 (0)1 45 60 77 20

Portugal

  • Menarini Portugal – Farmacêutica, S.A.

Tel: +351 210 935 500

Croatia

Berlin-Chemie Menarini Hrvatska d.o.o.

Tel: + 385 1 4821 361

Romania

Berlin-Chemie A.Menarini S.R.L.

Tel: +40 21 232 34 32

Ireland

Covis Pharma Europe B.V.

Tel: 1800937485

Slovenia

Berlin-Chemie/ A. Menarini Distribution Ljubljana d.o.o.

Tel: +386 01 300 2160

Iceland

Covis Pharma Europe B.V.

Sími: 8007279

Slovakia

Berlin-Chemie /A. Menarini Distribution Slovakia s.r.o.

Tel: +421 2 544 30 730

Italy

Laboratori Guidotti S.p.A.Tel: +39- 050 971011

Finland

Covis Pharma Europe B.V. Puh/Tel: 0800413687

Cyprus

Covis Pharma Europe B.V.

Τηλ: 80091079

Sweden

Covis Pharma Europe B.V. Tel: 0200898678

Latvia

SIA Berlin-Chemie/Menarini Baltic

Tel: +371 67103210

United Kingdom (Northern Ireland)

Covis Pharma Europe B.V. Tel: 08004334029

Date of Last Revision of this Leaflet:

Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu.

Instructions for Use

This section contains information on how to use your Genuair inhaler. It is important that you read this information, as Genuair may work differently from inhalers you have used before. If you have any questions about how to use your inhaler, ask your doctor, pharmacist, or nurse for help.

The instructions for use are divided into the following sections:

  • How to start
  • Step 1: Prepare your dose
  • Step 2: Inhale your medication
  • Additional information

The disposal of unused medication and all materials that have come into contact with it will be carried out in accordance with local regulations.

How to Start:

Read these instructions for use before starting to use the medication

Familiarize yourself with the parts of your Genuair inhaler

White and green inhaler with mouthpiece, protective cap, and control window with dose indicator and green button

Before Use:

  1. Before the first use, open the sealed bag and remove the inhaler. Dispose of the bag and the desiccant.
  2. Do not press the orange button until you are ready to inhale a dose.
  3. Remove the cap by gently pressing the arrows on either side (Figure B).

Hand holding a white and green auto-injector with arrow indicating pressure and text

STEP 1: Prepare your dose

  1. Check the mouthpiece opening and make sure nothing is blocking it (Figure C).
  1. Check the control window (it should be red, Figure C).

Gray auto-injector device with digital display showing the number 60 and red circular button

  1. Hold the inhaler horizontally with the mouthpiece facing you and the orange button at the top (Figure D).

Hand holding a white auto-injector with green protective cap showing how to hold it for injection

  1. Press the orange button down and all the way to load your dose (Figure E).

When you press the orange button down and all the way, the control window will change from red to green.

Make sure the orange button is up. Do not tilt it.

  1. Release the orange button (Figure F).

Make sure to release the button so that the inhaler can function correctly.

Two hands holding applicator devices with green cap showing arrows indicating direction of pressure

Stop and Check:

  1. Make sure the control window is now green (Figure G).

Your medication is ready to be inhaled.

Go to "STEP 2: Inhale your medication".

Silver auto-injector device with digital display showing the number 60 and green indicator light

What to do if the control window remains red after pressing the button (Figure H).

Insulin device with display showing the number 60 crossed out with a red diagonal cross

The dose is not prepared. Go back to "STEP 1 Prepare your dose" and repeat steps 1.1 to 1.6.

STEP 2: Inhale your medication

Read the complete steps from 2.1 to 2.7 before using. Do not tilt it.

2.1 Keep the inhaler away from your mouth and exhale completely.Never exhale into the inhaler (Figure I).

Profile of face showing open mouth and green arrow pointing into the oral cavity

2.2 Keep your head upright, place the mouthpiece between your lips, and close them tightly around the mouthpiece (Figure J).

Do not keep the orange button pressed while inhaling.

Hand holding a nasal inhaler pointing to the right nostril with visible medication spray

2.3 Take a strong and deep breaththrough your mouth. Continue breathing in for as long as possible.

A "click" will let you know that you have inhaled correctly. Continue breathing in for as long as possible after hearing the "click". Some patients may not hear the "click". Use the control window to make sure you have inhaled correctly.

2.4 Remove the inhaler from your mouth.

2.5 Hold your breath for as long as possible.

2.6 Breathe out slowly away from the inhaler.

Some patients may experience a gritty sensation in the mouth or a slightly sweet or bitter taste. Do not inhale an extra dose if you do not notice any taste or feel nothing after inhaling.

Stop and Check:

2.7 Make sure the control window is now red (Figure K). This means you have inhaled your medication correctly.

Silver auto-injector device with digital display showing the number 60 and red indicator line within a green frame

What to do if the control window remains green after inhaling (Figure L).

Insulin device with display showing the number 60 crossed out with a red cross on a white background with a green border

This means you have not inhaled your medication correctly. Go back to "STEP 2 Inhale your medication" and repeat steps 2.1 to 2.7.

If the control window still does not change to red, you may have forgotten to release the orange button before inhaling, or you may not have inhaled strongly enough. If this happens, try again. Make sure you have released the orange button and that you have exhaled completely. Then take a strong and deep breath through the mouthpiece.

Please contact your doctor if the control window remains green after several attempts.

Put the protective cap back on the mouthpiece after each use (Figure M), to prevent contamination of the inhaler with dust or other materials. You must discard your inhaler if you lose the cap.

Auto-injector device with green cap about to be removed by a hand showing directional arrow

Additional Information:

What should you do if you accidentally load a dose?

Keep your inhaler with the protective cap in place until it is time to inhale your medication, then remove the cap and start at step 1.6.

How does the dose indicator work?

  • The dose indicator shows the total number of doses left in the inhaler (Figure N).
  • On the first use, each inhaler contains at least 60 or 30 doses, depending on the package size.
  • Each time a dose is loaded by pressing the orange button, the dose indicator moves slightly to the next number (50, 40, 30, 20, 10, or 0).

When should you get a new inhaler?

You should get a new inhaler:

  • If your inhaler appears to be damaged or you lose the cap, or
  • When a red striped band appears on the dose indicator, this means you are approaching the last dose (Figure N), or
  • If your inhaler is empty (Figure O).

Gray device with dose indicator showing the number 10 and red striped band, arrows pointing to both elements

How do you know if your inhaler is empty?

When the orange button does not return to its upper position and remains stuck in a middle position, it has reached the last dose (Figure O). Even when the orange button is stuck, you can still inhale the last dose. After that, the inhaler cannot be used again and you should start using a new inhaler.

White auto-injector device with green top button and text

How should you clean the inhaler?

NEVER use water to clean the inhaler as it could damage your medication.

If you want to clean your inhaler, simply wipe the outside of the mouthpiece with a dry cloth or paper towel.

Online doctors for BRETARIS GENUAIR (Inhalation Capsule)

Discuss questions about BRETARIS GENUAIR (Inhalation Capsule), including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Марія Мартеллі

Anaesthesiology 12 years exp.

Dr Maria Martelli is a medical doctor specialising in anaesthesiology and pain medicine. She provides online consultations for adults, focusing on the assessment and management of acute, chronic, and complex pain conditions, as well as supportive care in serious illness.

She graduated from the Medical University of Silesia in Katowice and completed her specialisation in Anaesthesiology and Intensive Care. Alongside hospital work, she has extensive experience in home and inpatient hospice care, supporting patients with severe pain and advanced disease. Since 2021, she has been a certified specialist and continues to work in anaesthesiology, intensive care, and pain treatment.

Patients consult her for:

  • Chronic pain lasting more than 3 months (musculoskeletal, neuropathic, mixed pain).
  • Acute pain requiring medical assessment and treatment planning.
  • Post-operative pain and recovery support.
  • Cancer-related pain and symptom relief.
  • Palliative care support and quality-of-life improvement.
  • Adjustment and optimisation of pain medication.
  • Second opinions for complex or treatment-resistant pain.
Dr Martelli takes a structured, evidence-based approach, carefully analysing symptoms, previous treatments, and overall health status. Her consultations focus on realistic pain control goals, safety of therapy, and improving daily functioning.

She is especially attentive to patients living with long-term pain or serious illness, providing clear explanations, compassionate guidance, and medically sound recommendations adapted to each individual situation.

Camera Book a video appointment
€99
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55
0.0 (0)
Doctor

Марта Регеро Капілья

Allergology 8 years exp.

Dr Marta Reguero Capilla is an allergist and immunologist who works with both adults and children. She specialises in the diagnosis, treatment, and ongoing management of allergic and immune-related conditions through online consultations.

In her practice, Dr Reguero Capilla helps patients understand the causes of their symptoms, review test results, and choose appropriate treatment or monitoring strategies. Her consultations are suitable both for first-time assessments and for follow-up care over time.

Patients commonly consult Dr Marta Reguero Capilla for:

  • allergic rhinitis, seasonal allergies, and perennial allergy symptoms;
  • allergic conditions in adults and children;
  • bronchial asthma and allergy-related respiratory symptoms;
  • urticaria (acute and chronic) and angioedema;
  • food allergies and reactions to foods, additives, or medications;
  • atopic dermatitis, allergic rashes, and persistent itching;
  • unexplained or recurrent allergic reactions;
  • interpretation of laboratory tests, allergy testing, and immunology results;
  • immune system concerns, frequent infections, and reduced immune response;
  • ongoing medical follow-up and treatment adjustment.
Dr Reguero Capilla works in a structured and attentive manner, explaining medical decisions clearly and helping patients make informed choices about their own health or their child’s care.

When clinically appropriate, she may provide recommendations for further tests or referrals that patients can use within Spanish medical networks, including Sanitas and DKV, in accordance with the terms and conditions of those services.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for BRETARIS GENUAIR (Inhalation Capsule)?
BRETARIS GENUAIR (Inhalation Capsule) requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in BRETARIS GENUAIR (Inhalation Capsule)?
The active ingredient in BRETARIS GENUAIR (Inhalation Capsule) is aclidinium bromide. This information helps identify medicines with the same composition but different brand names.
How much does BRETARIS GENUAIR (Inhalation Capsule) cost in pharmacies?
The average pharmacy price for BRETARIS GENUAIR (Inhalation Capsule) is around 47.61 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures BRETARIS GENUAIR (Inhalation Capsule)?
BRETARIS GENUAIR (Inhalation Capsule) is manufactured by Covis Pharma Europe B.V.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BRETARIS GENUAIR (Inhalation Capsule) online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BRETARIS GENUAIR (Inhalation Capsule) is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BRETARIS GENUAIR (Inhalation Capsule)?
Other medicines with the same active substance (aclidinium bromide) include EKLIRA GENUAIR 322 micrograms powder for inhalation, ATROALDO 20 micrograms/PUFF pressurized inhalation solution, ATROVENT 20 micrograms PRESSURIZED INHALATION SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media